Effects of cytarabine and adamantoyl cytarabine on experimental allergic encephalomyelitis in rats.
D000311:Adrenal Glands / Q000502:physiology; D000315:Adrenalectomy; D000547:Amantadine / Q000627:therapeutic use*; D000818:Animals; D003561:Cytarabine / Q000627:therapeutic use*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000517:prevention & control*; D005260:Female; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D009705:Nucleosides / Q000627:therapeutic use*; D009929:Organ Size; D010243:Paralysis / Q000517:prevention & control; D051381:Rats; D013950:Thymus Gland / Q000033:anatomy & histology / Q000187:drug effects
D007166:Immunosuppressive Agents; D009705:Nucleosides; D003561:Cytarabine; D000547:Amantadine